TRV 102.37 The Travelers Companies Inc $TRV Hit a 52 week

New Post Public Reply Private Reply Replies (0) Message Board
DennyT
TRV 102.37 The Travelers Companies Inc $TRV Hit a 52 week high of 102.47 Currently at 102.37 +0.46 +0.45% With a day low of 101.70 and a total volume of 1,434,500.

TRV The Travelers Companies Inc Recent Headline News

ProAssurance Q3 Earnings Miss Estimates, Down Y/Y - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Thu Nov 06, 9:30AM CST
ProAssurance Corporation (PRA) reported third-quarter 2014 operating earnings per share of 68 cents, which lagged the Zacks Consensus Estimate of 73 cents.
ACE: 110.81 (+0.08), RLI: 49.31 (unch), PRA: 45.23 (+0.76), TRV: 102.37 (+0.46)

United Fire Posts In-Line Q3 Loss, Faces High Expense Drag - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Wed Nov 05, 10:00AM CST
United Fire (UFCS) reported third-quarter 2014 operating loss of one cent per share, in line with the Zacks Consensus Estimate.
UFCS: 30.26 (-0.09), ACE: 110.81 (+0.08), RLI: 49.31 (unch), TRV: 102.37 (+0.46)

RenaissanceRe Misses on Q3 Earnings as Revenues Decline - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Wed Nov 05, 8:30AM CST
RenaissanceRe's (RNR) third-quarter 2014 operating earnings per share of $2.49 missed the Zacks Consensus Estimate and declined year-over- year as revenues declined and expenses increased.
ACE: 110.81 (+0.08), RLI: 49.31 (unch), RNR: 101.58 (+0.27), TRV: 102.37 (+0.46)

SmarTrend Watching for Potential Pullback in Shares of Travelers After 1.18% Gain
Comtex SmarTrend(R) - Tue Nov 04, 4:34PM CST
Travelers (NYSE:TRV) traded in a range yesterday that spanned from a low of $99.82 to a high of $101.43. Yesterday, the shares gained 1.2%, which took the trading range above the 3-day high of $101.19 on volume of 2.9 million shares. Often times after large one-day gains, short term traders will seek to take profits and, as such, investors should be cautious.
TRV: 102.37 (+0.46)

Travelers Rises 1.18% on Heavy Volume: Watch For Potential Pullback
Comtex SmarTrend(R) - Tue Nov 04, 4:33PM CST
Travelers (NYSE:TRV) traded in a range yesterday that spanned from a low of $99.82 to a high of $101.43. Yesterday, the shares gained 1.2%, which took the trading range above the 3-day high of $101.19 on volume of 2.9 million shares. Often times after large one-day gains, short term traders will seek to take profits and, as such, investors should be cautious.
TRV: 102.37 (+0.46)

AmTrust Financial Beats on Q3 Earnings as Revenues Rise - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Tue Nov 04, 2:30PM CST
AmTrust Financial (AFSI) posted operating net earnings of $1.70 per share, surpassing the Zacks Consensus Estimate by 46% and being more than double the year-ago number on higher revenues.
ACE: 110.81 (+0.08), RLI: 49.31 (unch), AFSI: 49.89 (-0.58), TRV: 102.37 (+0.46)

3 Financial Stocks Pushing Sector Growth
at The Street - Tue Nov 04, 1:13PM CST
TheStreet highlights 3 stocks pushing the financial sector higher today.
ACE: 110.81 (+0.08), TRV: 102.37 (+0.46), MMC: 55.80 (-0.07)

Stocks Narrow Losses; Airlines Lead
at Investor's Business Daily - Tue Nov 04, 12:29PM CST
Stocks narrowed losses near midday Tuesday, but some leaders remained under pressure. The Nasdaq fell 0.6%, the S&P 500 dropped 0.4%, and the Dow Jones industrial average was down a fraction. Wal-Mart Stores (WMT), Travelers (TRV) and Procter &...
LCI: 50.17 (-0.82), SAVE: 77.31 (-0.49), WMT: 78.77 (+0.96), PG: 89.13 (+0.23), ATHM: 43.63 (-1.60), TXRH: 31.79 (-0.19), LUV: 38.24 (+0.30), TRV: 102.37 (+0.46)

Dow Jones (DJIA) Today: Travelers Companies (TRV) Higher
at The Street - Tue Nov 04, 12:00PM CST
The Dow component leading the way higher looks to be Travelers Companies (NYSE:TRV), which is sporting a $1.34 gain (+1.3%) bringing the stock to $101.28.
TRV: 102.37 (+0.46)

Dow Jones (DJIA) Today: Travelers Companies (TRV) Lower
at The Street - Mon Nov 03, 1:00PM CST
Holding back the Dow today is Travelers Companies (NYSE:TRV), which is lagging the broader Dow index with a 20-cent decline (-0.2%) bringing the stock to $100.60.
TRV: 102.37 (+0.46)

How Did These 20 Historically Strong October Stocks Hold Up?
at The Street - Mon Nov 03, 9:58AM CST
Historically, October is not the best month for stocks. This month's market volatility put the top 20 stocks in October to the test. Click through to see how they fared.
STT: 77.81 (-0.04), NUE: 54.18 (+0.70), DAL: 42.69 (-0.21), ICE: 218.54 (-1.38), MHFI: 89.94 (-0.05), ORCL: 39.94 (+0.13), ADBE: 71.60 (-0.50), MS: 35.66 (+0.35), ACE: 110.81 (+0.08), BTU: 11.64 (+0.80), GS: 190.71 (-0.29), R: 91.46 (+0.05), EXPD: 44.24 (+0.22), GOOGL: 551.82 (+0.13), SWN: 36.50 (+0.95), NDAQ: 43.88 (-0.02), AAPL: 109.01 (+0.31), MA: 84.80 (-0.95), TRV: 102.37 (+0.46)

Today's Water-Logged And Getting Wetter Stock: Travelers Companies (TRV)
at The Street - Thu Oct 30, 12:50PM CDT
Trade-Ideas LLC identified Travelers Companies (TRV) as a "water-logged and getting wetter" (weak stocks crossing below support with today's range greater than 200%) candidate
TRV: 102.37 (+0.46)

AXIS Capital Q3 Earnings Beat Estimates, Top Line Improves - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Thu Oct 30, 12:50PM CDT
AXIS Capital's (AXS) third-quarter 2014 earnings per share of $1.27 outperformed the Zacks Consensus Estimate by about 7% but slumped 27% year over year.
AXS: 49.46 (+0.29), ACE: 110.81 (+0.08), RLI: 49.31 (unch), TRV: 102.37 (+0.46)

CNO Financial's Q3 Earnings Beat Estimates, Improve Y/Y - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Wed Oct 29, 10:50AM CDT
CNO Financial Group Inc. (CNO) reported third-quarter 2014 operating earnings of 35 cents per share that was higher than the Zacks Consensus Estimate by 9.4%.
ACE: 110.81 (+0.08), RLI: 49.31 (unch), CNO: 18.12 (-0.08), TRV: 102.37 (+0.46)

Virginia Association of Community Banks Selects Travelers as Endorsed Provider for State's Community Banks
Business Wire - Tue Oct 28, 11:04AM CDT
Travelers (NYSE: TRV) has been selected by the Virginia Association of Community Banks (VACB) as an endorsed provider of bank insurance products. Member banks now have access through the Association to the Travelers property and casualty products, as well as SelectOne+(R) for Community Banks, which includes a broad set of coverages on specialty lines.
TRV: 102.37 (+0.46)

PartnerRe Earnings Top Estimates, Tank Y/Y on High Expense - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Tue Oct 28, 11:00AM CDT
PartnerRe Ltd.'s (PRE) third-quarter 2014 operating earnings beat the Zacks Consensus Estimate but lagged the year-ago quarter results.
PRE: 116.35 (-0.36), AFSI: 49.89 (-0.58), ENH: 58.20 (+0.46), TRV: 102.37 (+0.46)

Montpelier Q3 Earnings Beat, Down Y/Y on Less Underwriting - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Tue Oct 28, 10:50AM CDT
Montpelier's (MRH) operating earnings of 86 cents per share in the third quarter, beat the Zacks Consensus Estimate by a couple of cents but declined 38% year over year.
MRH: 32.81 (-0.01), ACE: 110.81 (+0.08), RLI: 49.31 (unch), TRV: 102.37 (+0.46)

XL Group Q3 Earnings Beat on Steady Growth in Underwriting - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Tue Oct 28, 10:40AM CDT
XL Group's (XL) third-quarter 2014 operating net income of 70 cents per share, which beat the Zacks Consensus Estimate by 9% marked four straight quarters of positive earnings surprise.
ACE: 110.81 (+0.08), RLI: 49.31 (unch), XL: 34.36 (+0.02), TRV: 102.37 (+0.46)
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Innovent's IBI3001 Shows Promise in Phase 1 Trials

Updated Category News Views 332

Pioneering Path with IBI3001 at ESMO 2026 Navigating through the crowded landscape of oncology trials, Innovent Biologics recently rolled out some riveting Phase 1 clinical data for their new darling, IBI3001. Top brass from Innovent took to the European Society for Medical Oncology (ESMO) Congress stage to lay bare their findings. Obviously, when you're presenting a...

Continue Reading
Sac-TMT's Phase III Success Shifts Lung Cancer Paradigm

Updated Category News Views 541

A New Era in Lung Cancer Treatment? Sac-TMT, the novel antibody-drug conjugate (ADC), just might be shaking up the non-small cell lung cancer (NSCLC) treatment landscape, and boy, is it making waves. Just when you think you’ve seen it all, here comes sacituzumab tirumotecan (sac-TMT), offering a glimmer of hope for patients whose treatment options have dwindled after...

Continue Reading
Lilly's Olomorasib: New Data Sparks Hope for G12C NSCLC

Updated Category News Views 225

New Data Unveiling Potential Shifts in NSCLC Treatment Man, if there's one thing the oncology world craved, it's progress against KRAS G12C-mutant non-small cell lung cancer (NSCLC). We're talking about a challenge as tough as a two-dollar steak. But hey, Eli Lilly's (NYSE:LLY) putting some serious cards on the table with olomorasib, and folks at the ESMO 2026 Congress...

Continue Reading
DigitalXForce Shakes Up GRC: AI-Infused X-ROC Launch

Updated Category News Views 130

Turning Risk Management on Its Head Well, here's a company not just tinkering around the edges but flipping the script on Governance, Risk, and Compliance (GRC) with their latest rollout: DigitalXForce and its X-ROC. Yeah, it's yet another acronym to juggle, but don't roll your eyes just yet. This AI-driven beast isn't about occasional boardroom reports. No sir, it's a...

Continue Reading
TORRAS Cases Balance Protection with Slim Design for 2026

Updated Category News Views 242

Are Slim iPhone Cases Really Protecting Your Investment? Anyone who's dropped a brand-new phone knows the pain of watching your investment smack the concrete. But hey, welcome to 2026, where Consumer365's latest rundown on iPhone protective gear turns the spotlight on TORRAS. These folks grabbed attention with their Q3 Air and Q3 Air Pro cases, crafted for iPhone 18 Pro...

Continue Reading
Clarins Dazzles Austin with Skin Longevity Event

Updated Category News Views 135

Clarins Takes Austin by Storm Under the vast Austin sky, something remarkable unfolded as Clarins transformed the scene with a flashy rooftop affair that screamed innovation and elegance. They weren’t just showing off fancy bottles of beauty potion; they were stirring the pot, merging science with a splash of high-end glitz. This wasn’t just another product pitch—it...

Continue Reading
Innovent's IBI354: New Data Spurs Hope for HER2+ BC

Updated Category News Views 222

Innovent Lauds HER2 ADC's Moment at ESMO 2026 Alright, chin up, investors. At the 2026 ESMO Congress, Innovent's throwing down some promising Phase 2 data for their brainchild, IBI354. You hear that name and it's like hearing about a rock star in the making in the oncology world. The potential here isn’t just talk—it's a loud, resounding call for attention. Their...

Continue Reading
Dr. Boonipat Inspires Future Women Surgeons at Texas Tech

Updated Category News Views 134

Sowing Surgical Seeds in Lubbock In Lubbock, Texas, something meaningful unfolded—an event the big market players would hardly blink at, but a significant step for the future of medicine. Led by Dr. Thanapoom "Mo" Boonipat, the founder of FacePlus Plastic Surgery Institute, a unique suturing workshop provided premed students at Texas Tech University hands-on experience...

Continue Reading
Borr Drilling's Rig Sinks, Uncertainty Looms Offshore

Updated Category News Views 228

Unexpected Turn of Events at Sea Now here's a gut-punch nobody saw coming. Borr Drilling Limited (NYSE and OSE: BORR) got hit hard when their Prospector 5 drilling rig went under the waves offshore Gabon. This ain't no desk job dilemma; we're talking about a real-life offshore catastrophe. It all went down on October 24, 2026, when the rig experienced a punch through...

Continue Reading
Gildan Activewear Faces Legal Battle Over Alleged Fraud

Updated Category News Views 176

Investor Alert: Gildan's Legal Showdown Alright, here's a twist you didn't see coming—or maybe you did if you've been tracking the ticker tapes like a hawk. Gildan Activewear Inc. (NYSE:GIL) is stuck in the kind of hot water that can scald the bottom line. The Stakes: Racing Towards December 14 Marked on your calendar, December 14, is a date of some significance if...

Continue Reading

Top 5 Most Recently Viewed Articles

Bouygues Enhances Shareholder Value Through Buyback Actions

Updated Category News Views 74

Bouygues Boosts Shareholder Value with Buyback Initiatives In corporate finance, share buybacks are often adopted as a strategic way to strengthen shareholder trust and increase stock value. Recently, Bouygues SA's trading activities have shown their dedication to creating value and aligning with the interests of their shareholders. Summary of Recent Buyback Activities...

Continue Reading
Warren Buffett's Investment in Occidental Faces Major Setback

Updated Category News Views 61

Warren Buffett's Investment Challenges with Occidental Petroleum Recently, Occidental Petroleum's shares dropped by 29% since mid-April, which has a direct impact on Warren Buffett’s large investment in the company. This decline raises concerns about potential strategies for future investments. Investment Context and Current Situation Chris Bloomstran, an experienced...

Continue Reading
Datavault AI Boosts WiSA Technology for Enhanced Home Audio

Updated Category News Views 275

Enhancing Audio Experience with Datavault AI's Innovations In the ever-evolving world of audio technology, Datavault AI has made significant strides to enhance the home audio experience. Through its Acoustic Science Division's Wireless Sound Association (WiSA), the company has launched several cutting-edge solutions designed to elevate audio quality while maintaining...

Continue Reading
Turkey Central Bank's Recent Interest Rate Reduction Explained

Updated Category News Views 297

Turkey's Central Bank Interest Rate Adjustment The central bank of Turkey has recently made headlines by announcing a significant reduction in its interest rate for the second consecutive time. This move is primarily attributed to a more pronounced slowdown in inflation that has taken place recently. Rate Cut Details The Monetary Policy Committee, led by the governor, has...

Continue Reading
Embracing Inclusivity: The Proud Pair Jewelry Initiative

Updated Category News Views 350

Embracing Inclusivity: The Proud Pair Jewelry Initiative In a significant step towards inclusivity, Hong Kong Marriage Equality has joined forces with the innovative local jewellery brand Playback Concept to unveil the "Proud Pair" collection. This unique initiative reimagines traditional jewellery by incorporating essential motifs that resonate with diverse gender...

Continue Reading